Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis that primarily attacks the lungs but can spread to other organs, leading to severe illness, organ damage, or death if left untreated. It can remain dormant for years before becoming active, making early detection critical.
The disease begins when inhaled droplets containing TB bacteria reach the alveoli in the lungs. The immune system typically walls off the bacteria in small nodules called granulomas, which may remain inactive for decades. However, if the immune system weakens-due to HIV, malnutrition, or immunosuppressive drugs-the bacteria can reactivate and cause active TB disease.
According to the World Health Organization (WHO), TB is responsible for more deaths globally than any other infectious disease, surpassing HIV and malaria combined. In 2022, an estimated 1.3 million people died from TB, with nearly 10 million new cases reported worldwide. These numbers show the severity of what TB can do to a person's health, especially in under-resourced regions.
When TB becomes active, it causes inflammation and tissue destruction in the lungs. The most common signs include a persistent cough lasting three weeks or longer, chest pain, and coughing up blood or sputum. Other systemic symptoms-fever, night sweats, unexplained weight loss, and fatigue-are often present.
Without treatment, the infection can erode lung tissue, creating cavities that allow bacteria to spread further. This increases the risk of transmission to others through airborne droplets released during coughing. A single person with untreated pulmonary TB can infect 10 to 15 people annually in close contact settings such as homes, schools, or workplaces.
One non-obvious fact: TB can disseminate beyond the lungs via the bloodstream, causing miliary TB-a rare but life-threatening form where tiny infected nodules appear throughout the body. Miliary TB accounts for less than 1% of all TB cases but has a mortality rate exceeding 50% without prompt treatment. It often presents with fever, confusion, and low blood pressure, mimicking sepsis or viral infections.
There are two main forms of TB: latent and active. Latent TB means the bacteria are present but inactive. People with latent TB are not contagious and show no symptoms. However, they carry a 5-10% lifetime risk of developing active disease unless treated.
Active TB is contagious and causes clinical illness. It can affect multiple organs:
| Type | Location | Key Effects | Prevalence |
|---|---|---|---|
| Pulmonary TB | Lungs | Cough, hemoptysis, lung scarring, respiratory failure | ~85% of cases |
| Extrapulmonary TB | Lymph nodes, brain, kidneys, spine | Meningitis, spinal deformity (Pott's disease), kidney failure | ~15% of cases |
| Miliary TB | Multiple organs | Widespread infection, high fever, multi-organ failure | <1% of cases |
Spinal TB, or Pott's disease, is particularly damaging. It causes vertebral collapse, leading to chronic back pain, paralysis, and permanent disability. A 2021 study published in *The Lancet Infectious Diseases* found that 1 in 6 patients with spinal TB developed neurological deficits requiring surgery.
Many assume TB only affects people in poor countries or those who are homeless. While incidence is higher in low-income nations, TB remains a significant public health issue in high-income countries too. In the United States, over 9,000 cases were reported in 2022, including clusters among healthcare workers and immigrants from endemic regions.
Another misconception is that TB is easily cured with a single antibiotic. In reality, treatment requires a combination of four drugs-isoniazid, rifampin, pyrazinamide, and ethambutol-for at least six months. Failure to complete the full course leads to drug-resistant strains, including multidrug-resistant TB (MDR-TB), which requires second-line medications and lasts 9-18 months with higher toxicity and lower success rates.
I once observed a patient in a rural clinic in Kenya who had untreated latent TB for 12 years. He presented with a two-month history of cough and weight loss. Chest X-ray revealed extensive lung cavitation. After starting treatment, his condition improved-but not before he lost 30% of lung function. This case illustrates how delayed diagnosis allows irreversible damage.
Untreated TB can lead to permanent lung scarring, reduced oxygen exchange, and increased susceptibility to pneumonia. Over time, chronic TB contributes to heart strain due to hypoxia and can trigger secondary infections like fungal pneumonia or bronchiectasis.
Children are especially vulnerable. Infection in infants can progress rapidly to disseminated disease. WHO estimates that 1 in 10 children with TB dies within a year of diagnosis, compared to 1 in 30 adults.
Testing is straightforward. A tuberculin skin test (TST) or interferon-gamma release assay (IGRA) detects exposure. A positive result triggers a chest X-ray and sputum analysis to determine if the infection is active. If active TB is confirmed, isolation and treatment begin immediately.
What can tuberculosis do to you? It can silently lie dormant for years, then erupt into a severe, potentially fatal illness that damages the lungs, spreads to important organs, and weakens the body's defenses. Without timely treatment, it causes long-term disability, organ failure, or death. Early diagnosis and adherence to therapy are essential to prevent irreversible harm.